-
MAKING VALUE-OF-INFORMATION TRACTABLE FOR PATIENT-LEVEL SIMULATION: A MACHINE-LEARNING EMULATOR FOR PROBABILISTIC ANALYSIS AND EVPPI OF DISCRETE-EVENT MODELS
Aug 25, 2026, 15:56 PM -
JOINT ESTIMATION OF MULTI-STATE TRANSITION PROBABILITIES USING KAPLAN-MEIER SURVIVAL CURVES
Aug 25, 2026, 15:56 PM -
EXPLORING STATISTICAL UNCERTAINTY OF HEALTH INTERVENTION EFFECTS IN DISCRETE CHOICE EXPERIMENTS: A FLU VACCINE CASE STUDY
Aug 25, 2026, 15:56 PM -
DECISION RULES FOR MULTI-TREATMENT RECOMMENDATIONS BASED ON NET MONETARY BENEFIT, FOR RISK-NEUTRAL AND RISK-AVERSE DECISION-MAKERS
Aug 25, 2026, 15:56 PM -
EVIDENCE GAPS AND STRATEGIC LESSONS FROM THE TOVORAFENIB CASE - A CRITICAL APPRAISAL OF FIRST EU JCA REPORT
Aug 25, 2026, 15:55 PM -
METHODOLOGICAL FIT BETWEEN THE EU JOINT CLINICAL ASSESSMENT AND EVIDENCE GENERATION FOR ADVANCED THERAPY AND ORPHAN MEDICINES
Aug 25, 2026, 15:55 PM -
ARE APPROVED THERAPIES ALWAYS THE MOST RELEVANT COMPARATORS? A LIVING EVIDENCE ANALYSIS OF REGULATORY-GUIDELINE-REIMBURSEMENT DIVERGENCE ACROSS SIX ONCOLOGY INDICATIONS
Aug 25, 2026, 15:55 PM -
HOW MANY PICOS CAN ONE ASSESSMENT CARRY? SCOPE AND FEASIBILITY IN EU JOINT CLINICAL ASSESSMENT
Aug 25, 2026, 15:55 PM -
EXAMINING HOW HEALTH EQUITY IS CONSIDERED IN HEALTH TECHNOLOGY ASSESSMENT: AN ANALYSIS OF DOCUMENTS FROM FOUR BODIES
Aug 25, 2026, 15:55 PM -
READINESS OF HEALTH TECHNOLOGY DEVELOPERS FOR EU JOINT CLINICAL ASSESSMENT: EVIDENCE REQUIREMENTS, OPERATIONAL CHALLENGES, AND NATIONAL HTA IMPLICATIONS
Aug 25, 2026, 15:55 PM -
CRITICAL ANALYSIS OF THE HISTORY AND IMPACT OF COST-EFFECTIVENESS THRESHOLDS: LESSONS AND INSIGHTS FOR DECISION-MAKERS
Aug 25, 2026, 15:55 PM -
REAL-WORLD DATA FOR MEDICAL DEVICE ARTIFICIAL INTELLIGENCE: A EUROPEAN HTA BODIES SURVEY
Aug 25, 2026, 15:55 PM -
INDIRECT TREATMENT COMPARISON FEASIBILITY ASSESSMENTS IN HEALTH TECHNOLOGY SUBMISSIONS: A REVIEW OF NICE TECHNOLOGY APPRAISALS
Aug 25, 2026, 15:55 PM -
EXTENDING MULTILEVEL NETWORK META-REGRESSION TO UNANCHORED NETWORKS AND SINGLE-ARM STUDIES
Aug 25, 2026, 15:55 PM -
FORWARD-LOOKING PICO: A PRIORITIZATION AND OPTIMIZATION FRAMEWORK TO SUPPORT GLOBAL HTA STRATEGY IN THE ERA OF JOINT CLINICAL ASSESSMENTS
Aug 25, 2026, 15:55 PM -
THE PRISMA-ECONEVAL 2026 STATEMENT: EXTENSION OF PRISMA AS A REPORTING GUIDELINE FOR SYSTEMATIC REVIEWS OF HEALTH ECONOMIC EVALUATIONS
Aug 25, 2026, 15:55 PM -
WHEN THE TAIL WAGS THE DOG III: A PERSIST-VERSUS-FADE EXTRAPOLATION CHOICE AND THE SURVIVAL RATIO SHIFT (RASOLUTE302)
Aug 25, 2026, 15:55 PM -
SURVIVAL MODELING USING COXIAN PHASE-TYPE DISTRIBUTION IN DISCRETE STATE-TRANSITION MODELS
Aug 25, 2026, 15:55 PM -
BAYESIAN INTEGRATION OF EXTERNAL TRIAL DATA IMPROVES LONG-TERM SURVIVAL EXTRAPOLATION IN MULTIPLE MYELOMA
Aug 25, 2026, 15:55 PM -
INTERVAL-CENSORED PROGRESSION-FREE SURVIVAL IN ONCOLOGY TRIALS - ESTIMATOR BIAS, PARAMETRIC EXTRAPOLATION, AND IMPLICATIONS FOR RESTRICTED MEAN SURVIVAL TIME
Aug 25, 2026, 15:55 PM
